US88033G4073
US88033G4073
Tenet Healthcare Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 21.24B EUR | 15.06B EUR | 16.25B EUR | 17.28B EUR |
Enterprise Value | 36.1B EUR | 26.14B EUR | 26.49B EUR | 27.57B EUR |
Valuation Multiples | ||||
Trailing P/E | 10.23x | 6.72x | 9.54x | 17.26x |
Forward P/E | 12.51x | -- | -- | -- |
Price to Sales | 0.97x | 0.67x | 0.74x | 1.07x |
Price to Book | 4.56x | 3.23x | 3.38x | 4.09x |
EV/Revenue | 1.66x | 1.15x | 1.21x | 1.71x |
EV/EBITDA | 7.45x | 4.57x | 5.18x | 7.89x |
Price to FCF (P/FCF) | 9.45x | 4.98x | 4.85x | 9.15x |
EV/FCF | 16.06x | 8.65x | 7.91x | 14.6x |
FCF Yield | 10.58% | 20.07% | 20.61% | 10.93% |